Deborah Townsley
Family · Madison, WVNPI 1881079614
Payments from drug & device makers
Across 242 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Pfizer$397
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$351
- AstraZeneca$282
- Lilly USA, LLC$258
- GSK$202
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,998100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 74 | $1,188 |
| Pfizer | 24 | $397 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $351 |
| AstraZeneca | 16 | $282 |
| Lilly USA, LLC | 15 | $258 |
| GSK | 13 | $202 |
| AbbVie | 10 | $200 |
| Novartis | 11 | $199 |
| Boehringer Ingelheim | 7 | $115 |
| Amgen | 7 | $110 |
| Bayer | 6 | $89 |
| Amarin Pharma, Inc. | 5 | $81 |
| Exact Sciences | 4 | $80 |
| Merck | 3 | $61 |
| Averitas Pharma Inc. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $40 |
| Evoke Pharma, Inc. | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Medtronic | 1 | $27 |
| Johnson & Johnson | 2 | $26 |
| Si-bone, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
How this compares
$3,998 in reported general payments places this provider in the 90th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $58,783 |
| FarxigaDapagliflozin Propanediol | 36 | $38,823 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $27,151 |
| EliquisApixaban | 37 | $22,731 |
| TrulicityDulaglutide | 23 | $20,708 |
| JanuviaSitagliptin Phosphate | 20 | $20,348 |
| XareltoRivaroxaban | 31 | $18,106 |
| LinzessLinaclotide | 12 | $17,382 |
| EntrestoSacubitril/Valsartan | 26 | $16,937 |
| JardianceEmpagliflozin | 15 | $12,334 |
| ElmironPentosan Polysulfate Sodium | 12 | $11,562 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $11,466 |
| TradjentaLinagliptin | 16 | $7,870 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $6,066 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $4,915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,188 | $58,78349 claims |
| AstraZenecaFarxiga, Symbicort | $282 | $44,89063 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $202 | $38,61758 claims |
| PfizerEliquis | $397 | $22,73137 claims |
| Lilly USA, LLCTrulicity | $258 | $20,70823 claims |
| MerckJanuvia | $61 | $20,34820 claims |
| Boehringer IngelheimJardiance, Tradjenta | $115 | $20,20431 claims |
| Johnson & JohnsonXarelto | $26 | $18,10631 claims |
| AbbVieLinzess, Synthroid | $200 | $18,06532 claims |
| NovartisEntresto | $199 | $16,93726 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,507 family providers in West Virginia.
Other family in Madison
- Brittany GriffithMadison$8K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.